Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema (left eye)
ICD-10 E09.3212 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema (left eye).
E09.3212 refers to diabetes mellitus that is induced by drugs or chemicals, characterized by the presence of mild nonproliferative diabetic retinopathy and macular edema specifically in the left eye. Drug-induced diabetes can occur due to various medications, including corticosteroids, antipsychotics, and certain chemotherapy agents. The condition is marked by elevated blood glucose levels, which can lead to long-term complications if not managed properly. Nonproliferative diabetic retinopathy is an early stage of diabetic eye disease where small blood vessels in the retina leak fluid, causing swelling and affecting vision. Macular edema, a common complication, occurs when fluid accumulates in the macula, leading to blurred vision. Management of this condition often involves controlling blood glucose levels through lifestyle changes, oral hypoglycemics, or insulin therapy, alongside monitoring and treating eye complications to prevent further vision loss.
Detailed medication history, HbA1c levels, and management plans.
Patients presenting with elevated glucose levels after starting new medications.
Ensure clear documentation of the relationship between medication and diabetes onset.
Visual acuity tests, retinal examination findings, and treatment plans for retinopathy.
Patients with diabetes presenting for routine eye exams or vision complaints.
Document specific findings related to macular edema and its impact on vision.
Used for follow-up visits for diabetes management.
Document history, examination findings, and management plan.
Endocrinology should document medication adjustments and HbA1c monitoring.
Medications such as corticosteroids, certain antipsychotics, and some chemotherapy agents are known to induce diabetes by affecting insulin secretion or action.
